6533b829fe1ef96bd128ac5b
RESEARCH PRODUCT
T1078 The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology
Konrads FunkaLimas KupčinskasAudrius IvanauskasMarcis LejaDainius JančiauskasHan-mo ChiuAgnese SudrabaLaimas Virginijus JonaitisJaw-town Linsubject
medicine.medical_specialtyPathologyHepatologybiologybusiness.industryAtrophic gastritisdigestive oral and skin physiologyGastroenterologymedicine.diseaseGastroenterologyIncreased riskAtrophyPepsinInternal medicinemedicinebiology.proteinBiomarker (medicine)HistopathologyCancer developmentbusinessGastric mucosal atrophydescription
Background Atrophy of the stomach mucosa is considered to be premalignant lesion for gastric cancer development; easy identification of this condition from a blood-sample would allow identifying the group of individuals at increased risk for cancer development.
year | journal | country | edition | language |
---|---|---|---|---|
2008-04-01 | Gastroenterology |